nulibry
tmc pharma (eu) limited - fosdenopterin hydrobromide dihydrate - metal metabolism, inborn errors - andre alimentary tract and metabolism produkter, - nulibry is indicated for the treatment of patients with molybdenum cofactor deficiency (mocd) type a.
roctavian
biomarin international limited - valoctocogene roxaparvovec - antihemorrhagics - treatment of severe haemophilia a (congenital factor viii deficiency) in adult patients without a history of factor viii inhibitors and without detectable antibodies to adeno-associated virus serotype 5 (aav5).
hemgenix
csl behring gmbh - etranacogene dezaparvovec - hæmofili b - other hematological agents - treatment of severe and moderately severe haemophilia b (congenital factor ix deficiency) in adult patients without a history of factor ix inhibitors.
xydalba
abbvie deutschland gmbh & co. kg - dalbavancin hydrochloride - soft tissue infections; skin diseases, bacterial - antibakterielle midler til systemisk brug, - behandling af akutte bakterielle hud- og hudstrukturinfektioner (absssi) hos voksne.
akynzeo
helsinn birex pharmaceuticals ltd - netupitant, palonosetron hydrochlorid - vomiting; neoplasms; nausea; cancer - antiemetika og antinauseants, - akynzeo er angivet i voksne til forebyggelse af akut og forsinket kvalme og opkastning i forbindelse med meget emetogenic cisplatin-baseret kemoterapi mod kræft. forebyggelse af akut og forsinket kvalme og opkastning i forbindelse med moderat emetogenic kræft kemoterapi.
tetmodis 25 mg tabletter
aop orphan pharmaceuticals gmbh - tetrabenazin - tabletter - 25 mg
azithromycin "jubilant" 250 mg filmovertrukne tabletter
jubilant pharmaceuticals nv - azithromycindihydrat - filmovertrukne tabletter - 250 mg
duofaxin 150 mg depottabletter
laboratorios liconsa s.a. - venlafaxinhydrochlorid - depottabletter - 150 mg
duofaxin 225 mg depottabletter
laboratorios liconsa s.a. - venlafaxinhydrochlorid - depottabletter - 225 mg
duofaxin 75 mg depottabletter
laboratorios liconsa s.a. - venlafaxinhydrochlorid - depottabletter - 75 mg